We use cookies to understand how you use our site and to improve your experience. This includes personalizing content and advertising. To learn more, click here. By continuing to use our site, you accept our use of cookies. Cookie Policy.
Features Partner Sites Information LinkXpress
Sign In
Advertise with Us
Ampronix,  Inc

Global Breast Imaging Market Worth USD 4.6 Billion by 2023

By Medimaging International staff writers
Posted on 06 Feb 2019
Print article
Image: The growth of the global breast imaging market is being driven mainly by technological advancements and rising incidence of breast cancer (Photo courtesy of iStock).
Image: The growth of the global breast imaging market is being driven mainly by technological advancements and rising incidence of breast cancer (Photo courtesy of iStock).
The global breast imaging market is projected to grow at a CAGR of 8.0% from USD 3.1 billion in 2018 to reach USD 4.6 billion by 2023, driven mainly by technological advancements and rising incidence of breast cancer. The market growth will be further aided by the rising adoption of advanced techniques for breast cancer screening and increasing government and private investments for improving breast cancer care.

These are the latest findings of MarketsandMarkets (Northbrook, IL, USA), a global market research company. On the basis of technology, the ionizing breast imaging technology segment is expected to account for the largest share of the breast imaging market during the forecast period, primarily due to technological advancements in ionizing breast imaging technologies and rising awareness about early screening and diagnosis of breast cancer. Based on type, the 3D breast tomosynthesis segment is expected to register the highest CAGR during the forecast period, driven by the growing demand for advanced screening technologies and increasing regulatory approvals for 3D breast tomosynthesis systems.

Geographically, North American accounted for the largest share of the global breast imaging market in 2018, due to rising incidence of breast cancer, easy accessibility and high adoption of advanced diagnostic technologies (owing to the significant per capita annual healthcare expenditure in the US and Canada), and rapidly increasing geriatric population in the region.

Related Links:
MarketsandMarkets


Print article
Italray
Radcal

Channels

Copyright © 2000-2019 Globetech Media. All rights reserved.